Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-15

FDA Approved: MESALAMINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved an original ANDA for mesalamine, authorizing Ascend Laboratories, LLC to market a generic version of the anti-inflammatory drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MESALAMINE (generic) (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)